anti-angiogenic

researchers are investigating anti-angiogenic therapies for cancer treatment.

anti-angiogenic drugs can starve tumors by inhibiting new blood vessel growth.

the anti-angiogenic effect of the drug was observed in preclinical studies.

combining anti-angiogenic agents with chemotherapy may improve outcomes.

targeting angiogenesis is a promising strategy in cancer therapy.

anti-angiogenic compounds are being developed to treat age-related macular degeneration.

the anti-angiogenic properties of this compound are under further investigation.

clinical trials are evaluating the efficacy of a new anti-angiogenic medication.

anti-angiogenic therapy aims to disrupt the tumor's blood supply.

the drug's anti-angiogenic activity was measured in vitro.

understanding the anti-angiogenic mechanisms is crucial for drug development.